Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Guardant Health Inc

GH
Current price
26.33 USD +1.15 USD (+4.57%)
Last closed 25.17 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 3 106 729 472 USD
Yield for 12 month -49.32 %
Week
Month
Year
GH
21.11.2021 - 28.11.2021

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360; Guardant360 LDT; Guardant360 CDx; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, a suite of advanced analytical technologies to enhance the performance and clinical utility of cancer tests. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. Guardant Health, Inc. has a research collaboration agreement with the Parker Institute for Cancer Immunotherapy to study the correlation between molecular cancer biomarkers and patient response to immunotherapy treatment across various types of cancer. The company was incorporated in 2011 and is headquartered in Palo Alto, California. Address: 505 Penobscot Drive, Redwood City, CA, United States, 94063

Analytics

WallStreet Target Price

49.22 USD

P/E ratio

Dividend Yield

Current Year

+449 538 000 USD

Last Year

+373 653 000 USD

Current Quarter

+143 030 000 USD

Last Quarter

+137 150 000 USD

Current Year

+293 213 000 USD

Last Year

+250 741 000 USD

Current Quarter

+85 416 000 USD

Last Quarter

+83 302 000 USD

Key Figures GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -476 216 000 USD
Operating Margin TTM -79.03 %
PE Ratio
Return On Assets TTM -18.52 %
PEG Ratio
Return On Equity TTM -218.88 %
Wall Street Target Price 49.22 USD
Revenue TTM 535 784 992 USD
Book Value 1.94 USD
Revenue Per Share TTM 4.96 USD
Dividend Share
Quarterly Revenue Growth YOY 21.8 %
Dividend Yield
Gross Profit TTM 293 213 000 USD
Earnings Share -4.03 USD
Diluted Eps TTM -4.03 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -80.69 %

Dividend Analytics GH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 6.4887
Price Sales TTM 5.7985
Enterprise Value EBITDA -7.1458
Price Book MRQ 13.6082

Financials GH

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators GH

For 52 weeks

20.67 USD 53.58 USD
50 Day MA 25.99 USD
Shares Short Prior Month 7 002 865
200 Day MA 29.85 USD
Short Ratio 3.05
Shares Short 6 344 863
Short Percent 5.61 %